BRIEF-Rigel Pharmaceuticals expects to report it had about $74.8 mln of cash, cash equivalents and short-term investments as of Dec 31 - SEC Filing
* Rigel Pharmaceuticals-Expects to report that it had about $74.8 million of cash, cash equivalents and short-term investments as of December 31, 2016 - SEC Filing Source text: [http://bit.ly/2kaak8b] Further company coverage: [Source]
Publication Date:Origin: reuters.com
Category: rbssHealthcareNews
Topics: equivalents, report, coverage, company, ly/2kaak8b] Further, //bit, [http, Filing Source, December, short-term investments, million, about $74, Pharmaceuticals-Expects, Rigel, Filing, investments, short-term, expects, Pharmaceuticals, BRIEF-Rigel
Source: http://feeds.reuters.com/~r/reuters/UShealthcareNews/~3/iJ-HoWbG_3c/idUSFWN1FK0QF